MapLight Therapeutics develops treatments for central nervous system disorders, with candidates in clinical trials for schizophrenia and autism. It last closed at $5.94 on Nov 20, down 7.48% on the day. The next earnings report for MPLT is expected around Thu, Mar 25, 2027. For the quarter ended Sep 2026, MPLT reported EPS of -$0.97. Over its last 6 reports the stock moved an average of 4.6% the session after earnings. Over the last 12 months MPLT insiders bought $66.2M of stock on the open market and sold $30.2M, according to SEC Form 4 filings.
AI Auto Pilots
Is MPLT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold MPLT.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on MPLTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
MPLT · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 19% below its 20 day and 45% below its 50 day average. It is 232% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 30), oversold. The nearest support is the 52 week low at $5.92, and the nearest resistance the Pivot at $6.12.
Short trendBearish
Long trendBearish
MomentumFading
StretchOversold
VolatilityNormal, 9.7%/day
Key levels
$40.4352 week high+580.6%
$19.70200 day average+231.6%
$14.53100 day average+144.6%
$8.6350 day average+45.3%
$7.80Swing high (Nov 11)+31.3%
$7.0820 day average+19.2%
$6.31Pivot R1+6.2%
$6.12Pivot+3.0%
$5.94Last close
$5.9252 week low−0.3%
$5.75Pivot S1−3.2%
Indicators
RSI (14)
29.94
Oversold below 30
Oversold
MACD
-0.65
Above its signal line
Bullish
Stochastic
18.4
Near the bottom of its range
Oversold
ADX (14)
45.3
Strong downtrend
Williams %R
-99.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-149.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−14.3%
Change over 10 sessions
Bearish
ATR (14)
$0.58
Typical daily range, 9.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling, oversold
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchOversold
VolatilityNormal, 48.2%/day
Key levels
$40.4352 week high+580.6%
$19.70200 day average+231.6%
$14.53100 day average+144.6%
$8.6350 day average+45.3%
$7.80Swing high (Nov 11)+31.3%
$7.0820 day average+19.2%
$6.31Pivot R1+6.2%
$6.12Pivot+3.0%
$5.94Last close
$5.9252 week low−0.3%
$5.75Pivot S1−3.2%
Indicators
RSI (14)
28.83
Oversold below 30
Oversold
MACD
-4.43
Below its signal line
Bearish
Stochastic
8.5
Near the bottom of its range
Oversold
ADX (14)
37.7
Trending down
Williams %R
-99.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-75.2
Oversold below −100, overbought above 100
Neutral
Rate of change
−54.3%
Change over 10 sessions
Bearish
ATR (14)
$2.87
Typical daily range, 48.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100–
MA 200–
What happened before, for MPLT
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how MPLT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for MPLTHow many large options trades hit MPLT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in MPLT in the last 90 days.
From SEC Form 4 filings by MPLT's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MPLT is in one of them and how their past MPLT trades turned out.
MapLight Therapeutics is a biopharmaceutical company based in Redwood City, California, that develops medicines for disorders of the central nervous system. Its main candidate, ML-007C-MA, is in clinical trials for schizophrenia and for psychosis linked to Alzheimer's disease. The company is also testing ML-004 for social communication difficulties in autism and has several preclinical programs. Its treatments are aimed at patients and the prescribers who care for them.